Detail of Certain Accounts

9 Months Ended

Sep. 30, 2022

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Detail of Certain Accounts

18. DETAIL OF CERTAIN ACCOUNTS:

Cash and Cash Equivalents

Amounts related to Quanta’s cash and cash equivalents based on geographic location of the bank accounts were as follows (in thousands):

	September 30, 2022		December 31, 2021
Cash and cash equivalents held in domestic bank accounts	$	175,846	$	205,781
Cash and cash equivalents held in foreign bank accounts	39,549		23,316
Total cash and cash equivalents	$	215,395	$	229,097

Quanta considers all highly liquid investments with an original maturity of three months or less at the time of purchase to be cash equivalents, which are carried at fair value. As of September 30, 2022 and December 31, 2021, cash equivalents were $136.7 million and $140.0 million and consisted primarily of money market investments and money market mutual funds and are discussed further in Note 17.

Cash and cash equivalents held by joint ventures, which are either consolidated or proportionately consolidated, are available to support joint venture operations, but Quanta cannot utilize those assets to support its other operations. Quanta generally has no right to cash and cash equivalents held by a joint venture other than participating in distributions, to the extent made, and in the event of dissolution. Cash and cash equivalents held by Quanta’s wholly-owned captive insurance company are generally not available for use in support of its other operations. Amounts related to cash and cash equivalents held by

consolidated or proportionately consolidated joint ventures and the captive insurance company, which are included in Quanta’s total cash and cash equivalents balances, were as follows (in thousands):

	September 30, 2022		December 31, 2021
Cash and cash equivalents held by domestic joint ventures	$	18,712	$	21,828
Cash and cash equivalents held by foreign joint ventures	5,087		3,461
Total cash and cash equivalents held by joint ventures	23,799		25,289
Cash and cash equivalents held by captive insurance company	46,539		133,302
Cash and cash equivalents not held by joint ventures or captive insurance company	145,057		70,506
Total cash and cash equivalents	$	215,395	$	229,097

Accounts Payable and Accrued Expenses

Accounts payable and accrued expenses consisted of the following (in thousands):

	September 30, 2022		December 31, 2021
Accounts payable, trade	$	1,383,079	$	1,251,118
Accrued compensation and related expenses	597,235		547,161
Other accrued expenses	429,286		456,392
Accounts payable and accrued expenses	$	2,409,600	$	2,254,671